In 2023, the tuberculosis treatment success rate for newly treated cases in India stood at 83%. The forecast indicates a steady increase from 84% in 2024 to 87% by 2028. This reflects a gradual year-on-year growth, with notable annual increases of approximately 1% for the first two years, leveling off with a reduced rate in subsequent years with a compound annual growth rate (CAGR) of about 1% over five years.
Future trends to watch for include further advancements in medical treatment, increased healthcare accessibility, and government initiatives aimed at TB eradication, which could positively impact treatment success rates. Additionally, monitoring drug resistance patterns and public health innovations will be crucial for sustaining and accelerating this progress.
